- Report
- February 2023
- 198 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- April 2018
Global
From €965EUR$1,000USD£828GBP
Silenor is a brand of central nervous system (CNS) drug used to treat insomnia. It is a non-benzodiazepine hypnotic, meaning it works by targeting certain receptors in the brain to induce sleep. It is used to treat difficulty falling asleep, staying asleep, and early morning awakenings. Silenor is taken orally, usually in the form of a tablet, and is generally taken shortly before bedtime.
Silenor is a relatively new drug, having been approved by the U.S. Food and Drug Administration in 2010. It is marketed by Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company based in San Diego, California.
Some other companies in the CNS drug market include Pfizer, Inc., GlaxoSmithKline, and Johnson & Johnson. Show Less Read more